Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This is a randomized double-blind three-arm trial to evaluate two dosages of CVT-E002 against
placebo in pediatric upper respiratory tract infections (URTI). It is hypothesized that
CVT-E002 use at standard doses reduces the duration of URTI in children aged 3-12 years.